Research programme: ubiquitin specific protease inhibitors - ATON
Alternative Names: HBX 19,818; HBX 41,108; HBX 96,819; USP inhibitors - ATON; USP8 inhibitors - ATONLatest Information Update: 28 Sep 2023
At a glance
- Originator Hybrigenics
- Developer ATON
- Class Small molecules
- Mechanism of Action Ubiquitin protein ligase complex inhibitors; Ubiquitin protein ligase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Pituitary ACTH hypersecretion